Sort
261,768 grants matching “gene therapy”
Therapeutic targets and novel anticancer agents for endocrine cancers
$926,461Naris Nilubol · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Center for Fetal Gene Transfer for Heart, Lung, and Blood Diseases
$926,398Alice F Tarantal · University Of California At Davis · R24 · FY2007 · HL
Center for Fetal Gene Transfer for Heart, Lung, and Blood Diseases
$926,398Alice F Tarantal · University Of California At Davis · R24 · FY2009 · HL
Creatine Safety and Efficacy in HD: Coordination and Statistical Center
$926,394Giovanni Schifitto · University Of Rochester · U01 · FY2015 · AT
A Therapeutic Vaccine for Chronic Hepatitis B
$926,325David R. Milich · Vlp Biotech, Inc. · R44 · FY2012 · AI
Interaction between nuclear epigenetic and metabolic pathways in cancer
$926,251Shelley L Berger · University Of Pennsylvania · R35 · FY2024 · CA
Gene Therapy for Batten Disease Using AAVrh.10 Expressing Human CLN2 cDNA
$926,056Ronald G Crystal · Weill Medical Coll Of Cornell Univ · R01 · FY2011 · NS
Third Generation Costimulation Blockade-Based Tolerance Strategies
$925,909Christian P Larsen · Emory University · U19 · FY2012 · AI
Cytokine Gene Therapy of Cancer - Preclinical Studies
$925,900Walter J Storkus · University Of Pittsburgh At Pittsburgh · P01 · FY2008 · CA
Intracellular Innate Immune Receptors in Cancer Suppression and Immunotherapy
$925,890Jenny P.y. Ting · Univ Of North Carolina Chapel Hill · R35 · FY2020 · CA
Intracellular Innate Immune Receptors in Cancer Suppression and Immunotherapy
$925,890Jenny P.y. Ting · Univ Of North Carolina Chapel Hill · R35 · FY2025 · CA
Intracellular Innate Immune Receptors in Cancer Suppression and Immunotherapy
$925,890Jenny P.y. Ting · Univ Of North Carolina Chapel Hill · R35 · FY2019 · CA
Stromal Regulation of Bone Metastasis
$925,878Raghu Kalluri · Beth Israel Deaconess Medical Center · U54 · FY2011 · CA
Xenobiotic Receptors in Mediating the Environmental Effects on Human Disease and Morbidity
$925,831Wen Xie · University Of Pittsburgh At Pittsburgh · R35 · FY2019 · ES
Dissecting Co-Dependent Pathways in Oral Cancers
$925,806John Chadwick Brenner · University Of Michigan At Ann Arbor · U01 · FY2018 · DE
Dissecting Co-Dependent Pathways in Oral Cancers
$925,806John Chadwick Brenner · University Of Michigan At Ann Arbor · U01 · FY2017 · DE
Elucidating and Targeting tumor dependencies and drug resistance determinants at the single cell level
$925,687Andrea Califano · Columbia University Health Sciences · U01 · FY2024 · CA
Sparking Advancements in Genomic Medicine
$925,611Julie A. Johnson · University Of Florida · U01 · FY2021 · HG
Effects of Mu-opiate receptor engagement on the persistence of HIV-associated activation and viral reservoirs in individuals receiving medication assisted treatment for opioid use disorder
$925,573Luis J. Montaner · Wistar Institute · R01 · FY2022 · DA
First-in-class ETS inhibitor TK216: Translational Biology and Oral Dosage Form Development
$925,560Gunnar Joerg Floris Kaufmann · Oncternal Therapeutics, Inc. · R44 · FY2021 · CA
Preservation of Proteomic Stability and Promotion of Protein Lipidation by HSF1
$925,537Chengkai Dai · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Papillomavirus Virion Proteins and Vaccines
$925,516Douglas R. Lowy · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
A Translational Program of BDNF Gene Delivery in Alzheimer's Disease
$925,483Mark H Tuszynski · University Of California, San Diego · U01 · FY2016 · AG
The Jackson Laboratory Knockout Mouse Production and Phenotyping Project (JAX KOMP2)
$925,466Robert E Braun · Jackson Laboratory · UM1 · FY2020 · OD
Maximizing the Effectiveness of PI3K Inhibitors in the Treatment of Pten null Cancers
$925,398Thomas M Roberts · Dana-Farber Cancer Inst · R35 · FY2019 · CA